Trials / Terminated
TerminatedNCT02095717
Multicenter Study Comparing Taxotere Plus Curcumin Versus Taxotere Plus Placebo Combination in First-line Treatment of Prostate Cancer Metastatic Castration Resistant (CURTAXEL)
- Status
- Terminated
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 50 (actual)
- Sponsor
- Centre Jean Perrin · Academic / Other
- Sex
- Male
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Multicenter randomized phase II study, double-blind, comparing Taxotere plus curcumin versus Taxotere plus placebo combination in first-line treatment of prostate cancer metastatic castration resistant. Assess time to progression (time to progression) of metastatic disease (from first day of treatment in the trial).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Curcumin | |
| DRUG | Placebo | |
| DRUG | Taxotere |
Timeline
- Start date
- 2014-03-01
- Primary completion
- 2018-04-01
- Completion
- 2018-04-01
- First posted
- 2014-03-26
- Last updated
- 2018-07-24
Locations
4 sites across 1 country: France
Source: ClinicalTrials.gov record NCT02095717. Inclusion in this directory is not an endorsement.